A randomized, open-Label, multicenter study assessing the effects of forced Exubera [inhaled insulin] dose titration on glycemic control in patients with suboptimally controlled type 2 diabetes on two or more oral antidiabetic agents
Phase of Trial: Phase III
Latest Information Update: 25 Jul 2007
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 25 Jul 2007 The expected completion date for this trial is now 1 Mar 2007.
- 15 May 2007 Status change from in progress to completed.